Thus, in agreement with our results, the spot 1 corresponding to serum RBP4, and the spot 3 correponding to GPx-3, showed significative increased concentrations in the T2DM patients presenting CVD compared to the controls (Figure 2). The gene discussed is GPX3; the disease is type 2 diabetes mellitus.